Posted inNews and Updates
FDA Approves IND for RXIM002: A Breakthrough for ITP
The FDA has cleared the IND for RXIM002, a novel circular RNA CAR-T therapy for ITP. Discover how this breakthrough could redefine treatment for the disorder.
Posted inNews and Updates
Indian Pharma Market Surges 12% Amid Low Unit Growth
Indian pharma records 12% revenue growth in July despite sluggish unit sales. Discover the factors driving this price-led market shift in our latest report.
Posted inNews and Updates
WHO Recommends Ervebo Vaccine for Ebola Clinical Trials
The WHO recommends the Ervebo vaccine for new clinical trials to combat Ebola. Learn how this move aims to improve outbreak response and vaccine efficacy.
Posted inNews and Updates
AI in Drug Discovery: Is the Multi-Billion Hype Justified?
Despite $8.9 billion in AI drug discovery investments, zero drugs have reached FDA approval. We analyze if the AI-driven biotech hype is nearing a reset.
Posted inNews and Updates
FDA Approves CLiK Extra to Combat New World Screwworm
The FDA has authorized CLiK Extra to protect livestock from New World screwworm. Learn how this new treatment improves parasite control for animals.
Posted inNews and Updates
Maharashtra FDA Revokes License of Pune Pharma Firm
Maharashtra FDA has revoked a Pune-based pharma firm's license following the discovery of contaminated medicines and severe Good Manufacturing Practices lapses.
Posted inNews and Updates
China Emerges as Global Powerhouse for Clinical Trials
China is rapidly becoming a global leader in medical research. Learn how regulatory reforms and infrastructure growth are shaping its clinical trial sector.
Posted inNews and Updates
BioVie Parkinson’s Trial Fails to Meet Primary Endpoint
BioVie shares plummet as Phase IIb study for Parkinson’s treatment NE3107 fails to meet primary endpoints in motor function improvement trials.
Posted inNews and Updates
Betting on Clinical Trials: Ethics and Risks Examined
The rise of betting on clinical trial outcomes sparks ethical concerns among experts. Discover the risks these prediction markets pose to medical research.
Posted inNews and Updates
AI Transforms Drug Discovery: Solving the $2B Problem
Discover how AI is revolutionizing drug development, reducing the $2 billion cost of research, and accelerating the path to life-saving medical breakthroughs.